Double-blind Controlled Trial of Prostacyclin in Cerebral Infarction

Completed

Phase N/A Results

Trial Description

Interventions

  • Prostacyclin (Epoprostenol)Drug
    Intervention Desc: Prostaglandin, presumed vasodilator.

Trial Design

Double-blind, controlled study involving 32 patients.

Patient Involvement

Patients received either prostacyclin or placebo intermittently for 65 hours.

Outcomes

Type Measure Time Frame Safety Issue
No outcomes associated with this trial.